SPECIALITY MEDICINES SHARE PRICE

Speciality Medicines Limited was originally incorporated as "Speciality Medicines Private Limited" as a Private Limited Company, dated February 05, 2021, issued by the Registrar of Companies, Central Registration Centre. Later on, the status was converted to Public Limited and the name of the Company was changed to "Speciality Medicines Limited" and a fresh Certificate of Incorporation dated June 25, 2024 was issued to the Company by Registrar of Companies. The Promoters, Parth B Goyani and Goyani Sumit Babubhai are associated with the Company and have a combined experience of more than 13 years in the pharmaceutical industry. The Company is engaged in marketing & distribution of finished formulations of Specialty pharmaceuticals - high-cost oral or injectable medications used to treat complex chronic conditions in Domestic as well as International Market. The Company has presence over 35 countries. The Company deal in Specialty pharmaceuticals finished formulations Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nasal Spray, Ointment, Ophthalmic, Oral Solution, Oral Suspension, Sachet, Suspension and Tablet. It provide a diverse portfolio of specialty pharmaceuticals, focusing on therapeutic areas such as oncology, immunology, neurology, and rare diseases. These products are designed to meet the complex needs of patients with chronic conditions, providing innovative solutions that improve health outcomes. The Company is collaborating with overseas distributors, many of whom work closely with the health ministries of various countries, as well as government and private hospitals. The Company is planning an IPO of upto 23,00,000 Equity Shares through Fresh Issue.

Speciality Medicines share price as on 01 Apr 2026 is Rs. 125. Over the past 6 months, the Speciality Medicines share price has increased by 0% and in the last one year, it has increased by 0%. The 52-week low for Speciality Medicines share price was Rs. 124 and 52-week high was Rs. 129.5.

Speciality Medicines Limited was originally incorporated as "Speciality Medicines Private Limited" as a Private Limited Company, dated February 05, 2021, issued by the Registrar of Companies, Central Registration Centre. Later on, the status was converted to Public Limited and the name of the Company was changed to "Speciality Medicines Limited" and a fresh Certificate of Incorporation dated June 25, 2024 was issued to the Company by Registrar of Companies. The Promoters, Parth B Goyani and Goyani Sumit Babubhai are associated with the Company and have a combined experience of more than 13 years in the pharmaceutical industry. The Company is engaged in marketing & distribution of finished formulations of Specialty pharmaceuticals - high-cost oral or injectable medications used to treat complex chronic conditions in Domestic as well as International Market. The Company has presence over 35 countries. The Company deal in Specialty pharmaceuticals finished formulations Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nasal Spray, Ointment, Ophthalmic, Oral Solution, Oral Suspension, Sachet, Suspension and Tablet. It provide a diverse portfolio of specialty pharmaceuticals, focusing on therapeutic areas such as oncology, immunology, neurology, and rare diseases. These products are designed to meet the complex needs of patients with chronic conditions, providing innovative solutions that improve health outcomes. The Company is collaborating with overseas distributors, many of whom work closely with the health ministries of various countries, as well as government and private hospitals. The Company is planning an IPO of upto 23,00,000 Equity Shares through Fresh Issue.

Speciality Medicines share price as on 01 Apr 2026 is Rs. 125. Over the past 6 months, the Speciality Medicines share price has increased by 0% and in the last one year, it has increased by 0%. The 52-week low for Speciality Medicines share price was Rs. 124 and 52-week high was Rs. 129.5.